The most important finding of this study was that DAN inhibited aberrant Ca2+ release by normalizing the CaM-RyR2 interaction, which in turn suppressed LV hypertrophy and fibrosis, thereby ameliorating LV relaxation and chamber stiffness in DOCA salt-induced hypertensive rats. Here, RYR2 is linked to cardiac hypertrophy.